Is EINECS 241-925-1 Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use EINECS 241-925-1? Is EINECS 241-925-1 safe for nursing mother and child? Does EINECS 241-925-1 extracts into breast milk? Does EINECS 241-925-1 has any long term or short term side effects on infants? Can EINECS 241-925-1 influence milk supply or can EINECS 241-925-1 decrease milk supply in lactating mothers?
EINECS 241-925-1 lactation summary
- DrLact safety Score for EINECS 241-925-1 is 7 out of 8 which is considered Dangerous as per our analyses.
- A safety Score of 7 indicates that usage of EINECS 241-925-1 may cause toxic or severe side effects in breastfed baby.
- Our study of different scientific research indicates that EINECS 241-925-1 may cause moderate to high side effects or may affect milk supply in lactating mother.
- Our suggestion is to use safer alternate options rather than using EINECS 241-925-1 .
- Usage of EINECS 241-925-1 is in contradiction to breastfeeding hence if it is must to use EINECS 241-925-1 and there is no better alternative available then breastfeeding shall be stopped permanently or temporarily.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Answer by Dr. Ru: About EINECS 241-925-1 usage in lactation
Anti-Parkinson drug, dopamine-agonist and synthetic ergotamine derivative that may inhibit prolactin release.
Answer by DrLact: About EINECS 241-925-1 usage in lactation
EINECS 241-925-1 is not approved for marketing in the United States by the U.S. Food and Drug Administration, but is available in other countries. It lowers serum prolactin and is approved in some countries for lactation suppression. Some experts recommend EINECS 241-925-1 as a safer alternative to bromocriptine for lactation suppression, but others recommend avoiding all lactation suppressants.[1][2] Data are insufficient recommend one treatment for lactation suppression over another.[3]
EINECS 241-925-1 Possible Effects in Breastfeeding
EINECS 241-925-1 suppresses serum prolactin increases in a dose-related fashion.[4][5] Comparative studies have found EINECS 241-925-1 comparable in efficacy to bromocriptine, although rebound lactation occurred in more patients treated with EINECS 241-925-1 0.4 mg daily than in those treated with bromocriptine 5 mg daily.[6][7] Rebound lactation appears to be less with a higher dose of 0.6 mg daily and with 15 days of therapy rather than 10 days.[8][9]
Alternate Drugs
Levodopa(Unsafe)
Cabergoline(Unsafe)
Bromocriptine(Unsafe)
Amantadine(Low Risk)
Lisuride(Dangerous)
Pramipexole(Unsafe)
Ropinirole(Unsafe)
Cabergoline(Unsafe)
Bromocriptine(Unsafe)
Lisuride(Dangerous)
Pramipexole(Unsafe)
Ropinirole(Unsafe)
Lisuride(Dangerous)